BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells

Gamma Irradiation Upregulates B-cell Translocation Gene 2 to Attenuate Cell Proliferation of Lung Cancer Cells Through the JNK and NF-κB Pathways

(2017) Peihe Wang et al.   ONCOLOGY RESEARCH

Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells

(2016) Ke-Hung Tsui et al.   CANCER LETTERS

Inhibitory effects of B-cell translocation gene 2 on skin cancer cells via the Wnt/β-catenin signaling pathway

(2016) Shou-Song Gao et al.   Molecular Medicine Reports

Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells

(2015) Jehn-Chuan Lee et al.   CANCER LETTERS

Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes

(2015) J-A Choi et al.   ONCOGENE

Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells

(2015) Ke-Hung Tsui et al.   Scientific Reports

BTG2: A rising star of tumor suppressors (Review)

(2014) BIJING MAO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Topoisomerase Inhibitors Modulate Gene Expression of B-Cell Translocation Gene 2 and Prostate Specific Antigen in Prostate Carcinoma Cells

(2014) Kun-Chun Chiang et al.   PLoS One

Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways

(2014) Kun-Chun Chiang et al.   Scientific Reports

Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients

(2013) N Wagener et al.   BRITISH JOURNAL OF CANCER

PTEN modulators: a patent review

(2013) Chandra S Boosani et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Mechanisms by Which Interleukin-6 Attenuates Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells

(2013) Ke-Hung Tsui et al.   Biomed Research International

BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria

(2012) Seo-Kyung Lim et al.   CLINICAL & EXPERIMENTAL METASTASIS

Current perspectives in bladder cancer management

(2012) T. R. L. Griffiths et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Lack of progress in bladder cancer—what are the obstacles?

(2012) Mark S. Soloway   Nature Reviews Urology

Raloxifene Inhibits Growth of RT4 Urothelial Carcinoma Cells via Estrogen Receptor-Dependent Induction of Apoptosis and Inhibition of Proliferation

(2012) Kristi L. Hoffman et al.   Hormones & Cancer

Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells

(2011) Ke-Hung Tsui et al.   INTERNATIONAL JOURNAL OF CANCER

The mammalian anti-proliferative BTG/Tob protein family

(2009) G. Sebastiaan Winkler   JOURNAL OF CELLULAR PHYSIOLOGY

BTG/TOB factors impact deadenylases

(2009) Fabienne Mauxion et al.   TRENDS IN BIOCHEMICAL SCIENCES

Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-Cell translocation gene 2

(2008) Ke-Hung Tsui et al.   PROSTATE